| Medical and Health Sciences | 2021-2025 | 964 | PL 6 | 99.77 |
| Dermatology | Lifetime | 78 | PL 2 | 99.46 |
| Rheumatology | Lifetime | 555 | PL 1 | 97.43 |
| Immunology and Allergy | Lifetime | 676 | PL 2 | 86.08 |
| Dermatology | 2021-2025 | 40 | PL 2 | 99.37 |
| Immunology | 2021-2025 | 92 | PL 1 | 98.27 |
| Rheumatology | 2021-2025 | 114 | PL 1 | 97.35 |
| Epidemiology | 2021-2025 | 428 | PL 3 | 96.27 |
| Pathology and Forensic Medicine | 2021-2025 | 433 | PL 4 | 81.66 |
| Dermatology and Skin Diseases | Lifetime | 132 | PL 2 | 99.23 |
| Urticaria and Related Conditions | Lifetime | 84 | PL 2 | 98.98 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 135 | PL 2 | 98.72 |
| Autoimmune Bullous Skin Diseases | Lifetime | 236 | PL 5 | 98.18 |
| Allergic Rhinitis and Sensitization | Lifetime | 407 | PL 5 | 98.34 |
| Nail Diseases and Treatments | Lifetime | 259 | PL 4 | 97.72 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 335 | PL 3 | 96.80 |
| Dermatological and COVID-19 studies | Lifetime | 211 | PL 2 | 90.45 |
| Acne and Rosacea Treatments and Effects | Lifetime | 422 | PL 2 | 92.10 |
| Skin Protection and Aging | Lifetime | 999 | PL 12 | 92.83 |
| Dermatological and Skeletal Disorders | Lifetime | 511 | PL 3 | 91.47 |
| Medicine and Dermatology Studies History | Lifetime | 349 | PL 3 | 90.08 |
| Skin Diseases and Diabetes | Lifetime | 421 | PL 6 | 89.23 |
| Complementary and Alternative Medicine Studies | Lifetime | 999 | PL 2 | 89.37 |
| Hair Growth and Disorders | Lifetime | 812 | PL 10 | 87.42 |
| Body Image and Dysmorphia Studies | Lifetime | 849 | PL 5 | 85.27 |
| Tattoo and Body Piercing Complications | Lifetime | 445 | PL 6 | 59.36 |
| Dermatology and Skin Diseases | 2021-2025 | 45 | PL 2 | 99.28 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 42 | PL 2 | 98.12 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 55 | PL 1 | 98.77 |
| Urticaria and Related Conditions | 2021-2025 | 40 | PL 2 | 98.10 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 68 | PL 1 | 96.09 |
| Medicine and Dermatology Studies History | 2021-2025 | 10 | PL 1 | 93.08 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 110 | PL 3 | 94.65 |
| Asthma and respiratory diseases | 2021-2025 | 492 | PL 4 | 95.38 |
| Dermatological and COVID-19 studies | 2021-2025 | 40 | PL 1 | 89.86 |
| Dermatological and Skeletal Disorders | 2021-2025 | 58 | PL 1 | 86.68 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 554 | PL 9 | 91.52 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 401 | PL 5 | 89.82 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 993 | PL 4 | 88.55 |
| Nail Diseases and Treatments | 2021-2025 | 307 | PL 11 | 85.71 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 410 | PL 4 | 82.91 |
| Skin and Cellular Biology Research | 2021-2025 | 186 | PL 3 | 80.59 |
| Complementary and Alternative Medicine Studies | 2021-2025 | 360 | PL 4 | 79.96 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 289 | PL 2 | 80.71 |
| Hair Growth and Disorders | 2021-2025 | 311 | PL 11 | 79.75 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 786 | PL 10 | 74.34 |
| Cancer and Skin Lesions | 2021-2025 | 744 | PL 21 | 68.41 |
| Skin Diseases and Diabetes | 2021-2025 | 237 | PL 6 | 66.80 |
| Mast cells and histamine | 2021-2025 | 894 | PL 21 | 62.54 |
| Body Image and Dysmorphia Studies | 2021-2025 | 964 | PL 16 | 52.38 |
| Genetic and rare skin diseases. | 2021-2025 | 519 | PL 10 | 49.94 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 935 | PL 26 | 45.43 |
| Therapeutic Uses of Natural Elements | 2021-2025 | 537 | PL 20 | 44.38 |
| Dupuytren's Contracture and Treatments | 2021-2025 | 242 | PL 2 | 41.90 |
| Tattoo and Body Piercing Complications | 2021-2025 | 191 | PL 8 | 24.24 |
